Vertex Pharmaceuticals Inc. buy Bank of America Co.
Start price
14.10.24
/
50%
€444.75
Target price
14.10.25
€496.10
Performance (%)
-20.33%
End price
15.10.25
€354.35
Summary
This prediction ended on 15.10.25 with a price of €354.35. The price of Vertex Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.33%. Bank_of_America_Co_ has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.509% | -1.509% | -13.165% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Bank of America Co. from $550.00 to $541.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€377.00
19.12.24
19.12.24
€503.63
19.12.25
19.12.25
2.18%
12.12.25
12.12.25
Stopped prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€456.50
31.03.25
31.03.25
€523.00
31.03.26
31.03.26
-15.62%
12.12.25
12.12.25